Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell Carcinoma
Condition(s):Renal Cell CarcinomaLast Updated:September 21, 2016Completed
Hide Studies Not Open or Pending
Condition(s):Renal Cell CarcinomaLast Updated:September 21, 2016Completed
Condition(s):Localized Renal Cell CarcinomaLast Updated:July 28, 2009Unknown status
Condition(s):Carcinoma, Renal CellLast Updated:March 22, 2023Completed
Condition(s):Renal Cell Carcinoma; Clear Cell Renal Cell CarcinomaLast Updated:July 12, 2021Not yet recruiting
Condition(s):Renal Cell CarcinomaLast Updated:January 5, 2021Terminated
Condition(s):Metastatic Renal Cell CarcinomaLast Updated:November 23, 2015Withdrawn
Condition(s):Advanced Kidney CancerLast Updated:October 19, 2020Withdrawn
Condition(s):Carcinoma, Renal CellLast Updated:March 24, 2023Recruiting
Condition(s):Kidney CancerLast Updated:June 19, 2020Completed
Condition(s):Carcinoma, Renal CellLast Updated:March 22, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.